https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Background Very preterm infants are at high risk of death or severe morbidity. The objective was to determine the significance of severe congenital heart defects (CHDs) for these risks. Methods and Results This cohort study included infants from 10 countries born from 2007-2015 at 24 to 31 weeks' gestation with birth weights less then 1500 g. Severe CHDs were defined by International Classification of Diseases, Ninth Revision (ICD-9) and Tenth (ICD-1 codes and categorized as those compromising systemic output, causing sustained cyan
Like
Comment
Share
